Ecological patterns and processes of temporal turnover within lung infection microbiota

Helen Gavillet1, Lauren Hatfield2, Andrew Jones3

  • 1Department of Applied Sciences, Northumbria University, Newcastle, UK.

Microbiome
|March 25, 2024
PubMed
Abstract

Insights

Chronic lung infections in cystic fibrosis (CF) involve dynamic microbial communities. Understanding these temporal shifts, driven by resident and transient bacteria, is key for effective treatment strategies in CF and other airway diseases.

Area of Science:

  • Ecology and Microbiology
  • Investigates the ecological dynamics of polymicrobial infections in the human lung.
  • Applies island biogeography principles to understand microbial community turnover.

Background:

  • Chronic lung infections in cystic fibrosis (CF) are complex polymicrobial issues, not simple 'one microbe, one disease' scenarios.
  • Lung microbiota are temporally dynamic, necessitating consideration of time-dependent changes in disease association.
  • Previous studies often overlooked the temporal and ecological aspects of lung microbial communities.

Discussion:

  • Lung microbiota can be categorized into persistent (chronic) and transient (intermittent) colonizers, revealing distinct ecological behaviors.
  • Chronic colonizers are stable and persistent, primarily influenced by deterministic processes like homogenizing dispersal.
  • Transient colonizers, representing new arrivals, drive overall microbiota turnover through stochastic processes like drift.

Key Insights:

  • Chronic colonizers in CF lungs are more extensive than previously recognized by culture-based methods.
  • Microbial turnover in chronic colonizers is conserved, driven by deterministic dispersal.
  • Turnover in the broader microbiota is driven by transient species through stochastic drift.

Outlook:

  • The study introduces a novel ecological framework for understanding temporal microbial dynamics in CF lung infections.
  • This framework has translational potential for improved therapeutic targeting of lung microbiota.
  • The findings are applicable to CF and other chronic airway diseases with polymicrobial infections.